Clinical Trial

The Efficacy and Safety of Short-course Radiation Combined With Adebrelimab and CAPEOX Neo-adjuvant Therapy for Organ-retention in Patients With MSS/pMMR Ultra Low Rectal Adenocarcinoma

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated February 20, 2024 (before its estimated January 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the efficacy, safety and organ retention rate of short-course radiation combined with Adebrelimab and CAPEOX neoadjuvant therapy in patients with MSS/pMMR ultra low rectal adenocarcinoma.
Trial Details
NCT Number NCT06266832
Lead Sponsor Sir Run Run Shaw Hospital
Conditions Rectal Adenocarcinoma
Enrollment 30 participants
Start Date 2024-01-01
Primary Completion 2025-01-01 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-02-20